Loading...
ROCO
1796
Market cap44mUSD
Jul 09, Last price  
34.40TWD
1D
-9.95%
1Q
-13.13%
Jan 2017
-58.55%
IPO
-58.05%
Name

GeneFerm Biotechnology Co Ltd

Chart & Performance

D1W1MN
ROCO:1796 chart
P/E
49.42
P/S
2.11
EPS
0.70
Div Yield, %
5.81%
Shrs. gr., 5y
8.25%
Rev. gr., 5y
12.95%
Revenues
677m
+29.92%
328,230,000368,303,000522,334,000633,963,000793,770,000521,163,000677,098,000
Net income
29m
P
-27,550,0004,529,00057,413,00093,454,000124,621,000-22,528,00028,862,000
CFO
99m
+1,127.59%
14,687,00056,419,000112,233,000122,434,000190,313,0008,090,00099,312,000
Dividend
Jul 10, 20242 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GeneFerm Biotechnology Co., Ltd. specializes in the development, production, and global distribution of fermented health and wellness products, serving both the Taiwanese domestic market and international clients. The company's extensive product line includes a variety of microbial fermentation offerings such as different types of mushrooms, lactic acid bacteria, other bacterial strains, yeast, and algae. Furthermore, GeneFerm provides a wide array of bio-fermented ingredients, including specialized powders like nattomena, natto fermented powder, red yeast rice fermented powder, and various mycelial powders (e.g., antrodia cinnamomea, cordyceps, reishi, phellinus linteus, armillaria mellea). They also supply beta-glucan powder, fermented fruit and vegetable enzymes, as well as probiotic and peptide components. Beyond its product sales, GeneFerm offers additional services such as private label supplement manufacturing, packaging equipment, and expert microbial fermentation toll manufacturing and consulting. Established in 1988, the company maintains its headquarters in Tainan City, Taiwan.
IPO date
Jul 26, 2016
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT